Pie Medical Imaging announced the release of CAAS IntraVascular 2.0, the dedicated software for analysis of intravascular ultrasound (IVUS), near-infrared spectroscopy (NIRS)-IVUS and optical coherence tomography (OCT) datasets. This new release contains an optimized OCT analysis and the in-depth analysis of NIRS-IVUS datasets. Data can be imported easily from the console or picture archiving and communication system (PACS) into the study list, which provides a clear overview of your data. CAAS IntraVascular has U.S. Food and Drug Administration (FDA) 510(k) clearance for both IVUS and OCT.


According to a new report on the Europe market for interventional cardiology by iData Research, drug-eluting stents accounted for a significant portion of the European markets for interventional cardiology devices in 2014. The advent of drug-eluting stents has driven the interventional cardiology market beyond expectations, as these devices have managed to increase the size of the market by virtue of their relatively high average selling price (ASP). New developments in drug-eluting stents such as biodegradable materials are expected to keep the market competitive despite safety concerns regarding late stent thrombosis.


Colegio Argentino de Cardioangiólogos Intervencionistas

Innovations in Cardiovascular Interventions

Coronary Artery Disease Case-based Learning (Mayo)

Hawaii Heart: Echo and Multimodality Imaging (Mayo)

Arrhythmias and the Heart (Mayo)

The American Society of Echocardiography (ASE) released a new document describing various imaging strategies for diagnosing a “hole in the heart,” one of the most common types of congenital heart defects. The document, Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions, describes the various defects, the modalities used to evaluate them, and clearly lays out strategies for optimal imaging.

Cases in Echo, Cardiac CT and MRI (Mayo)

Subscribe Now